Defining Quality Tolerance Limits and Key Risk Indicators for Timely Risk Detection: Series Part 3: Methods for early detection of risk.
- Published in:
- Applied Clinical Trials, 2022, v. 31, n. 9, p. 34
- By:
- Publication type:
- Article
Works matching IS 10648542 AND DT 2022 AND VI 31 AND IP 9
Results: 13
1
2
Clinical Research Needs Greater Participant Diversity.
- Published in:
- Applied Clinical Trials, 2022, v. 31, n. 9, p. 42
- By:
- Publication type:
- Article
3
Four Key Trends for Identifying Regulator and Payer Evidence Needs in Oncology Drug Development: How to leverage novel trial designs and real-world data to support a cancer drug submission with an evidence strategy that is both approvable and reimbursable
- Published in:
- Applied Clinical Trials, 2022, v. 31, n. 9, p. 14
- By:
- Publication type:
- Article
4
CONTEMPLATING A PRESSING DRUG DEVELOPMENT PARADOX.
- Published in:
- Applied Clinical Trials, 2022, v. 31, n. 9, p. 12
- By:
- Publication type:
- Article
5
The Eradication of False Signals in Monitoring: How optimizing RBQM risk detection reduces the efforts caused by false signals.
- Published in:
- Applied Clinical Trials, 2022, v. 31, n. 9, p. 26
- By:
- Publication type:
- Article
6
The Powerful Impact of Caregivers on Clinical Trials: Considering caregiver-supported trials to improve patient retention and outcomes.
- Published in:
- Applied Clinical Trials, 2022, v. 31, n. 9, p. 23
- By:
- Publication type:
- Article
7
'Record' Gains in Bringing Research Closer to the Patient: Experts discuss solving the EHR-compatibility puzzle in point-of-care trials.
- Published in:
- Applied Clinical Trials, 2022, v. 31, n. 9, p. 19
- By:
- Publication type:
- Article
8
DATA COLLECTION.
- Published in:
- Applied Clinical Trials, 2022, v. 31, n. 9, p. 10
- Publication type:
- Article
9
FILLING THE GAPS IN CLINICAL TRIAL EDUCATION, LITERACY.
- Published in:
- Applied Clinical Trials, 2022, v. 31, n. 9, p. 8
- By:
- Publication type:
- Article
10
GETTING UP TO SPEED ON NEW TRIAL APPLICATION SYSTEM HITS HIGH GEAR.
- Published in:
- Applied Clinical Trials, 2022, v. 31, n. 9, p. 7
- By:
- Publication type:
- Article
11
TOP PRIORITY FOR CALIFF IS COMBATING HEALTH MISINFORMATION.
- Published in:
- Applied Clinical Trials, 2022, v. 31, n. 9, p. 6
- By:
- Publication type:
- Article
12
CRAACO, Moving Trials Closer to Patients.
- Published in:
- Applied Clinical Trials, 2022, v. 31, n. 9, p. 4
- By:
- Publication type:
- Article
13
NEW PATHS TO POINT OF CARE.
- Published in:
- Applied Clinical Trials, 2022, v. 31, n. 9, p. 1
- By:
- Publication type:
- Article